Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 3/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3136989 | 0.98 | SLC6A2 (0.54) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL24340783 | 0.87 | SMN1; SMN2 (0.47) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL27829250 | 0.85 | SLC6A2 (0.54) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL7785582 | 0.85 | L3MBTL1 (0.54) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL1147656 | 0.84 | SLC6A2 (0.52) | SLC6A2TAAR1SMN1; SMN2HIF1ACYP3A4 | |
| SCHEMBL517462 | 0.84 | SMN1; SMN2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1ACYP3A4 | |
| SCHEMBL28869480 | 0.84 | MAPT (0.51) | SLC6A2MAPTKMT2ACYP3A4CYP1A2 | |
| SCHEMBL5268840 | 0.83 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL407787 | 0.83 | SLC6A2 (0.57) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT | |
| SCHEMBL1059557 | 0.83 | SLC6A2 (0.52) | SLC6A2TAAR1SMN1; SMN2HIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017216726-A1 | SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-12-21 | — | — | WO | claimed |
| US-8221733-B2 | Acyclic or carbocyclic amines as antiseptics for bathroom fixtures | LONZA AG (CH) | 2012-07-17 | — | — | US | claimed |
| US-20100216890-A1 | Disinfectant | LONZA AG (CH) | 2010-08-26 | — | — | US | claimed |
| US-20050277573-A1 | Disinfectant | LONZA AG (CH) | 2005-12-15 | — | — | US | claimed |
| US-6939840-B2 | Disinfectant | LONZA AG (CH) | 2005-09-06 | — | — | US | claimed |
| US-20050089496-A1 | Virucidal disinfectant | Arxada Switzerland AG (CH) | 2005-04-28 | — | — | US | claimed |
| US-20040029767-A1 | Disinfectant | LONZA SOLUTIONS AG (CH) | 2004-02-12 | — | — | US | claimed |
| US-5245004-A | ANHYDROUS POLYMERIZATION OF CAPROLACTAM WITH CATALYST, COCATALYST AND ACTIVATOR | UNITIKA LTD. (JP) | 1993-09-14 | — | — | US | claimed |
| EP-0522533-A1 | Process for polymerizing epsilon-caprolactam | UNITIKA LTD. (JP) | 1993-01-13 | — | — | EP | claimed |
| CN-115151550-B | External nucleotide pyrophosphatase/phosphodiesterase 1 (ENPP 1) modulators and uses thereof | 桑福德·伯纳姆·普雷比医学发现研究所 | 2024-11-22 | — | — | CN | disclosed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | disclosed |
| CN-117897439-A | Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | disclosed |
| CN-117897440-A | Method for screening solvent for extraction of polyvinyl chloride, method for recycling waste material, recycled polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | disclosed |
| WO-2024012554-A1 | TPK AGONIST AND METHOD FOR TREATING NEURODEGENERATIVE DISEASES USING SAME | 上海日馨医药科技股份有限公司 | 2024-01-18 | — | — | WO | disclosed |
| EP-0751927-A4 | SYNTHESIS OF COMPOUNDS WITH PREDETERMINED CHIRALITY | CALIFORNIA INST OF TECHN (US) | 1998-07-29 | — | — | EP | disclosed |
| CN-1142492-A | Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents | PFIZER (US) | 1997-02-12 | — | — | CN | disclosed |
| EP-0751927-A1 | SYNTHESIS OF COMPOUNDS WITH PREDETERMINED CHIRALITY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1995025714-A1 | SYNTHESIS OF COMPOUNDS WITH PREDETERMINED CHIRALITY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1995-09-28 | — | — | WO | disclosed |
| US-5245004-A | ANHYDROUS POLYMERIZATION OF CAPROLACTAM WITH CATALYST, COCATALYST AND ACTIVATOR | UNITIKA LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| EP-0522533-A1 | Process for polymerizing epsilon-caprolactam | UNITIKA LTD. (JP) | 1993-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050089496-A1 | Virucidal disinfectant | O60361, GP6, PSMB6 | SLC6A2 2258/4885TAAR1 165/4885SMN1; SMN2 2169/4885 |
| US-20100216890-A1 | Disinfectant | SCN1B, ALDH7A1, SCNN1B | SLC6A2 2601/4885TAAR1 249/4885SMN1; SMN2 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.